[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100597788":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":21,"responsibleParty":35,"collaborators":10,"id":37,"slug":38,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":41,"acronym":10,"eligibilityCriteria":42,"healthyVolunteers":43,"sex":44,"minAge":45,"maxAge":10,"enrollmentInfo":46,"targetDuration":10,"studyType":49,"phases":10,"briefSummary":50,"conditions":51,"keywords":53,"overallStatus":23,"whyStopped":10,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},{"fullName":5,"class":6},"Shanghai East Hospital","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Research group",null,"Thirty patients with cardiovascular diseases were enrolled as the research group.",{"label":13,"type":10,"description":14,"interventionNames":10},"Healthy controls","Ten healthy individuals were enrolled as the healthy controls.",[16],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Jie Ding, MD","CONTACT","086-38804518","dingjie940406@163.com",[22],{"facility":5,"status":23,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":10},"RECRUITING","Shanghai","Shanghai Municipality","200120","China","CN",{"type":30,"coordinates":31},"Point",[32,33],121.45806,31.22222,{"lat":33,"lon":32},{"type":36,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100597788","clinical-research-on-68ga-fapi-petcmr-in-cardiovascular-diseases-100597788",false,"NCT07063043","Clinical Research on 68Ga-FAPI PET\u002FCMR in Cardiovascular Diseases","Inclusion Criteria:\n\n* Participants must have a confirmed clinical diagnosis of cardiovascular disease by a cardiologist, based on genetic testing, family history, and comprehensive clinical evaluation including physical examination, echocardiography, and when indicated, cardiac MRI findings.\n* Age requirement: \\>18 years.\n* Patients should demonstrate stable cardiovascular status without significant changes in symptoms, treatment, or clinical findings for a specified pre-enrollment period.\n* Participants must be capable of providing informed consent and willing to adhere to all study requirements, including follow-up procedures.\n\nExclusion Criteria:\n\n* History of malignancy\n* Documented cardiovascular diseases, including coronary artery disease, myocardial infarction, or related conditions\n* Implanted metallic devices (e.g., pacemakers, aneurysm clips) or other MRI-incompatible medical prostheses\n* Claustrophobia\n* Pregnancy or lactation\n* Known hypersensitivity to gadolinium-based contrast agents\n* Renal impairment (eGFR \\\u003C30 mL\u002Fmin\u002F1.73m² by CKD-EPI equation)",true,"ALL","18 Years",{"count":47,"type":48},40,"ESTIMATED","OBSERVATIONAL","FAP-targeted PET imaging using 68Ga-FAPI enables early detection of myocardial fibrosis. Combined PET\u002FCMR provides comprehensive cardiac assessment without extra radiation. This advanced imaging approach improves diagnosis and personalized treatment for better patient outcomes.",[52],"Cardiovascular Diseases (CVD)",[54,55,56],"Cardiovascular diseases","FAPI","PET\u002FMR","2025-07-03",{"date":59,"type":60},"2025-07-14","ACTUAL",{"date":62,"type":60},"2024-12-01",{"date":64,"type":48},"2028-12-31",{"name":5,"class":6},1]